Genpact Limited
G
$51.64
$0.631.24%
| Weiss Ratings | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C | |||
| Reward Grade | B | |||
| Rating Factors | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Good | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.10 | |||
| Price History | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -2.35% | |||
| 30-Day Total Return | 11.85% | |||
| 60-Day Total Return | 14.74% | |||
| 90-Day Total Return | 34.90% | |||
| Year to Date Total Return | 20.12% | |||
| 1-Year Total Return | 52.10% | |||
| 2-Year Total Return | 13.54% | |||
| 3-Year Total Return | 31.40% | |||
| 5-Year Total Return | 52.11% | |||
| 52-Week High % Change | -10.13% | |||
| 52-Week Low % Change | 68.74% | |||
| Price | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $56.76 | |||
| 52-Week Low Price | $30.23 | |||
| 52-Week Low Price (Date) | Apr 18, 2024 | |||
| 52-Week High Price (Date) | Feb 07, 2025 | |||
| Valuation | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 8.96B | |||
| Enterprise Value | 9.73B | |||
| Price/Earnings (TTM) | 17.96 | |||
| Earnings Per Share (TTM) | 2.84 | |||
| Earnings Per Share Growth | -17.17% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 1.92 | |||
| Price/Book (Q) | 3.73 | |||
| Enterprise Value/Revenue (TTM) | 2.04 | |||
| Price | $51.64 | |||
| Enterprise Value/EBITDA (TTM) | 12.29 | |||
| Enterprise Value/EBIT | 13.95 | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 179.18M | |||
| Dividend Yield | 1.20% | |||
| Div. Per Share (Most Recent) | $0.15 | |||
| Dividend Per Share (TTM) | $0.61 | |||
| Payout Ratio (TTM) | 21.12% | |||
| Dividend Per Share (Most Recent) | $0.15 | |||
| Company Info | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | (441) 298-3300 | |||
| Address | -- | |||
| Website | www.genpact.com | |||
| Country | Bermuda | |||
| Year Founded | 1997 | |||
| Profitability | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.63% | |||
| Profit Margin | 10.77% | |||
| Management Effectiveness | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.90% | |||
| Return on Equity | 22.15% | |||
| Income Statement | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 4.77B | |||
| Total Revenue (TTM) | 4.77B | |||
| Revenue Per Share | $26.60 | |||
| Gross Profit (TTM) | 1.69B | |||
| EBITDA (TTM) | 791.65M | |||
| EBIT (TTM) | 697.50M | |||
| Net Income (TTM) | 513.67M | |||
| Net Income Avl. to Common (TTM) | 513.67M | |||
| Total Revenue Growth (Q YOY) | 8.94% | |||
| Earnings Growth (Q YOY) | -51.28% | |||
| EPS Diluted (TTM) | 2.84 | |||
| EPS Diluted Growth (Q YOY) | -50.25% | |||
| Balance Sheet | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 675.49M | |||
| Cash Per Share (Q) | $3.77 | |||
| Total Current Assets (Q) | 2.08B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 2.39B | |||
| Current Ratio (Q) | 2.158 | |||
| Book Value Per Share (Q) | $13.68 | |||
| Total Assets (Q) | 4.99B | |||
| Total Current Liabilities (Q) | 963.74M | |||
| Total Debt (Q) | 1.45B | |||
| Total Liabilities (Q) | 2.60B | |||
| Total Common Equity (Q) | 2.39B | |||
| Cash Flow | G - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -105.96M | |||
| Cash from Financing (TTM) | -424.85M | |||
| Net Change in Cash (TTM) | 64.58M | |||
| Levered Free Cash Flow (TTM) | 426.65M | |||
| Cash from Operations (TTM) | 615.42M | |||
